Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

[Review] Biological therapies for rheumatoid arthritis: An overview for the clinician

dc.contributor.authorFindeisen, Kate E
dc.contributor.authorSewell, Julia
dc.contributor.authorOstor, Andrew
dc.date.accessioned2024-02-21T01:53:50Z
dc.date.available2024-02-21T01:53:50Z
dc.date.issued2021
dc.date.updated2022-10-09T07:17:49Z
dc.description.abstractRheumatoid arthritis (RA) is a disease characterised by inflammation of synovial joints and poses a substantial healthcare burden on both the individual and society. One of the most significant shifts in the RA therapeutic landscape has occurred with the introduction of biological disease modifying anti-rheumatic drugs (bDMARDs). There are five classes of bDMARDs currently available, each with a different molecular target and subtle differences in their efficacy and safety profile. This review also describes the “real-world” use of bDMARDs and how they fit into the overall RA treatment guidelines.en_AU
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn1177-5475en_AU
dc.identifier.urihttp://hdl.handle.net/1885/313795
dc.language.isoen_AUen_AU
dc.provenanceThis work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php)en_AU
dc.publisherDove Medical Press Ltden_AU
dc.rights© 2021 The authorsen_AU
dc.rights.licenseCreative Commons Attribution licenceen_AU
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/en_AU
dc.sourceBiologics: Targets and Therapyen_AU
dc.subjectrheumatoid arthritisen_AU
dc.subjectbiological therapiesen_AU
dc.subjectbDMARDsen_AU
dc.title[Review] Biological therapies for rheumatoid arthritis: An overview for the clinicianen_AU
dc.typeJournal articleen_AU
dcterms.accessRightsOpen Accessen_AU
local.bibliographicCitation.lastpage352en_AU
local.bibliographicCitation.startpage343en_AU
local.contributor.affiliationFindeisen, Kate E, The Alfred Hospital, Melbourne VIC Australiaen_AU
local.contributor.affiliationSewell, Julia, The Alfred Hospital, Melbourne VIC Australiaen_AU
local.contributor.affiliationOstor, Andrew, College of Health and Medicine, ANUen_AU
local.contributor.authoruidOstor, Andrew, u1121502en_AU
local.description.notesImported from ARIESen_AU
local.identifier.absfor320223 - Rheumatology and arthritisen_AU
local.identifier.absfor320402 - Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)en_AU
local.identifier.ariespublicationa383154xPUB32824en_AU
local.identifier.citationvolume15en_AU
local.identifier.doi10.2147/BTT.S252575en_AU
local.identifier.scopusID2-s2.0-85113236544
local.publisher.urlhttps://www.dovepress.com/en_AU
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
BTT-252575-biological-therapies-for-rheumatoid-arthritis--an-overview-f.pdf
Size:
482.25 KB
Format:
Adobe Portable Document Format
Description: